GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Albert Labs International Corp (XCNQ:ABRT) » Definitions » Scaled Net Operating Assets

Albert Labs International (XCNQ:ABRT) Scaled Net Operating Assets : -6.10 (As of Sep. 2023)


View and export this data going back to 2022. Start your Free Trial

What is Albert Labs International Scaled Net Operating Assets?

Scaled Net Operating Assets (SNOA) is calculated as the difference between operating assets and operating liabilities, scaled by lagged total assets.

Albert Labs International's operating assets for the quarter that ended in Sep. 2023 was C$0.07 Mil. Albert Labs International's operating liabilities for the quarter that ended in Sep. 2023 was C$0.50 Mil. Albert Labs International's Total Assets for the quarter that ended in Jun. 2023 was C$0.07 Mil. Therefore, Albert Labs International's scaled net operating assets (SNOA) for the quarter that ended in Sep. 2023 was -6.10.


Albert Labs International Scaled Net Operating Assets Historical Data

The historical data trend for Albert Labs International's Scaled Net Operating Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Albert Labs International Scaled Net Operating Assets Chart

Albert Labs International Annual Data
Trend Dec21 Dec22
Scaled Net Operating Assets
-1.62 -1.24

Albert Labs International Quarterly Data
Mar21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23
Scaled Net Operating Assets Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.07 -0.72 -2.73 -2.93 -6.10

Competitive Comparison of Albert Labs International's Scaled Net Operating Assets

For the Biotechnology subindustry, Albert Labs International's Scaled Net Operating Assets, along with its competitors' market caps and Scaled Net Operating Assets data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Albert Labs International's Scaled Net Operating Assets Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Albert Labs International's Scaled Net Operating Assets distribution charts can be found below:

* The bar in red indicates where Albert Labs International's Scaled Net Operating Assets falls into.



Albert Labs International Scaled Net Operating Assets Calculation

Scaled Net Operating Assets (SNOA) is calculated as the difference between operating assets and operating liabilities, scaled by lagged total assets.

Albert Labs International's Scaled Net Operating Assets (SNOA) for the fiscal year that ended in Dec. 2022 is calculated as

Scaled Net Operating Assets (SNOA)(A: Dec. 2022 )
=(Operating Assets (A: Dec. 2022 )-Operating Liabilities (A: Dec. 2022 ))/Total Assets (A: Dec. 2021 )
=(0.085-0.529)/0.358
=-1.24

where

Operating Assets(A: Dec. 2022 )
=Total Assets - Cash, Cash Equivalents, Marketable Securities
=0.164 - 0.079
=0.085

Operating Liabilities(A: Dec. 2022 )
=Total Liabilities - Long-Term Debt & Capital Lease Obligation - Short-Term Debt & Capital Lease Obligation
=0.529 - 0 - 0
=0.529

Albert Labs International's Scaled Net Operating Assets (SNOA) for the quarter that ended in Sep. 2023 is calculated as

Scaled Net Operating Assets (SNOA)(Q: Sep. 2023 )
=(Operating Assets (Q: Sep. 2023 )-Operating Liabilities (Q: Sep. 2023 ))/Total Assets (Q: Jun. 2023 )
=(0.065-0.498)/0.071
=-6.10

where

Operating Assets(Q: Sep. 2023 )
=Total Assets - Cash, Cash Equivalents, Marketable Securities
=0.065 - 0
=0.065

Operating Liabilities(Q: Sep. 2023 )
=Total Liabilities - Long-Term Debt & Capital Lease Obligation - Short-Term Debt & Capital Lease Obligation
=0.508 - 0.01 - 0
=0.498

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Albert Labs International Scaled Net Operating Assets Related Terms

Thank you for viewing the detailed overview of Albert Labs International's Scaled Net Operating Assets provided by GuruFocus.com. Please click on the following links to see related term pages.


Albert Labs International (XCNQ:ABRT) Business Description

Traded in Other Exchanges
N/A
Address
6996, Merritt Avenue, Burnaby, BC, CAN, V5J 4R6
Albert Labs International Corp is a laboratory-based, clinical research and drug development enterprise addressing mental health care needs. The company is focusing on Real World Evidence (RWE) the company will initially look to commercialize its mycelium-based KRN-101 medicine and treatment with the help of clinical pathway.

Albert Labs International (XCNQ:ABRT) Headlines

No Headlines